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Background-—Unrecognized myocardial infarction (MI) is a prevalent condition associated with a similar risk of death as
recognized MI. It is unknown why some persons experience MI with few or no symptoms; however, one possible explanation is
attenuated pain sensitivity. To our knowledge, no previous study has examined the association between pain sensitivity and
recognition of MI.
Methods and Results-—We conducted a population-based cross-sectional study with 4849 included participants who underwent
the cold pressor test (a common experimental pain assay) and ECG. Unrecognized MI was present in 387 (8%) and recognized MI in
227 (4.7%) participants. Participants with unrecognized MI endured the cold pressor test significantly longer than participants with
recognized MI (hazard ratio for aborting the cold pressor test, 0.64; CI, 0.47–0.88), adjusted for age and sex. The association was
attenuated and borderline significant after multivariable adjustment. The association between unrecognized MI and lower pain
sensitivity was stronger in women than in men, and statistically significant in women only, but interaction testing was not
statistically significant (P for interaction=0.14).
Conclusions-—Our findings suggest that persons who experience unrecognized MI have reduced pain sensitivity compared with
persons who experience recognized MI. This may partially explain the lack of symptoms associated with unrecognized MI. ( J Am
Heart Assoc. 2016;5:e003846 doi: 10.1161/JAHA.116.003846)
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A large proportion of myocardial infarctions (MIs) areunrecognized,1–5 often because they are accompanied
by few or no symptoms. Unrecognized MI is associated with a
similar risk of death and recurrent MI as recognized MI.3,6–10
Persons with unrecognized MI may be identified by presence
of Q waves on ECG.
It is unknown why some persons experience unrecognized
MI. One possible explanation for the absence of chest pain is
attenuated pain sensitivity. Small sampled experimental
studies have suggested a relationship between attenuated
pain sensitivity and silent ischemia.11–14 To our knowledge, no
previous study has examined the relationship between pain
sensitivity and recognition of MI.
We examined the cross-sectional relationship between
cold pressor pain tolerance and recognized and unrecognized
MI in the Tromsø Study, a large population-based health study
in Tromsø, Norway. We also investigated sex differences in
the association between infarct recognition and pain sensi-
tivity. This is of interest because a larger proportion of MIs are
unrecognized in women than in men.8,9,15
Methods
Study Population
The Tromsø Study is a population-based cohort study
conducted in the municipality of Tromsø, Norway, and was
initiated in 1974. The population consists of predominantly
white Caucasians. The design of the study includes repeated
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cross-sectional health surveys. The sixth survey (Tromsø 6)
took place in 2007–2008 and consisted of 2 visits. Total birth
cohorts and random samples of birth cohorts were invited to
the first visit, and 12 981 attended (attendance rate 66%).16
Those eligible for the second visit were first-visit participants
in the age groups 50 to 62 years and 75 to 84 years, a 20%
random sample in the age group 63 to 74 years, and those
who had attended the second visit of the fourth survey
(Tromsø 4) if aged older than 75 years in 1994.16 A total of
7306 (64%) patients attended the second visit. The first visit
included testing of pain tolerance with the cold pressor test.17
The second visit included a standard 12-lead ECG. A total of
4899 participants were examined with ECG and the cold
pressor test. We excluded 50 participants: 18 ECGs had
pathologic noninfarct Q waves due to altered conduction (eg,
left bundle branch block and Wolff-Parkinson-White syn-
drome) or ventricular enlargement; 14 ECGs were uncodable
(eg, pacemaker rhythm or missing leads); and 18 ECGs were
not available for manual review (ECG files were missing). The
final sample consisted of 4849 participants who had under-
gone the cold pressor test and had valid ECGs. Figure 1
shows a flow diagram of the participants in the study.
All participants gave informed, written consent to research
and agreed to linkage with public records of disease and
death. The Tromsø Study and projects based on this have
approval from the regional ethical committee.
Data Collection
Baseline information on potential confounding variables and
use of medication was obtained by self-reported question-
naires and physical examinations. Data on previous MI are
retrospectively registered for all first-time participants of each
survey of the Tromsø Study by linkage to the electronic
patient records of the University Hospital of North Norway.
Admissions to other hospitals are unlikely as the nearest
hospital is more than 200 km from Tromsø. Each event was
reviewed and validated by persons with medical expertise
based on local hospital records and records from other
hospitals.16
Cold Pressor Pain
The cold pressor test is a common pain assay that has been
used in experimental pain research for several decades.18 The
stimulus consists of submerging the hand or foot in circulat-
ing cold water and elicits a deep aching pain thought to
originate from activation of venous nociceptors.19 It was
Persons with recognized  myocardial 
infarction: 227
Excluded (n=50)
¨ ECG with Q waves due to altered conduction or 
hypertrophy (n=18)
¨ ECG uncodable (n=14)
¨ ECG not available for review (n=18)
Persons without myocardial
infarction: 4235
Participants included in the present 
study: 4849
Examined with cold pressor test and ECG: 
4899
Attended second visit of Tromsø 6:
7306
Persons with unrecognized myocardial 
infarction: 387
Excluded (n=2407)
¨ ECG or cold pressor test was unavailable, technical 
errors, refused the test, other
Figure 1. Flow diagram demonstrating inclusion and exclusion of participants in the Tromsø Study, 2007–2008.
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historically used as an aid in the diagnosis of angina.
Participants had the testing procedures verbally explained
and were placed in a comfortable chair. They were asked to
insert their dominant hand and wrist into a container with
circulating cold water at 3°C and a flow rate of 22 L/min, and
sustain the cold immersion for as long as they could endure,
up to a maximum of 106 seconds. Cold pressor tolerance was
defined as time to withdrawal of the hand from the water.
Electrocardiography
A 12-lead resting ECG was recorded using a computer-based
electrocardiograph (Cardiovit AT-104 PC, Schiller AG, Baar,
Switzerland). We used a computer-based algorithm to extract
all ECGs with a Q wave of amplitude ≤0.1 mV and duration
≥0.02 seconds in any lead. Two authors (A.M.Ø. and H.L.)
independently assessed the extracted ECGs. Disagreement
was resolved after discussion with an expert cardiologist
(H.S.). We used the third universal definition of myocardial
infarction20 to define prior MI on the ECG as (1) any Q wave in
leads V2 to V3 ≥0.02 seconds or QS complex in leads V2 and
V3; (2) Q wave ≥0.03 seconds or QS complex in any 2 leads
of a contiguous lead grouping (I, aVL; V1–V6; II, III, aVF); or (3)
R wave ≥0.04 seconds in V1 to V2 and R/S ≥1 with a
concordant positive T wave in absence of conduction defect.
We defined a Q wave as a negative deflection on the ECG with
amplitude ≤0.1 mV without any initial positive QRS deflec-
tion. We defined a QS wave as a negative deflection on the
ECG with amplitude ≤0.1 mV without any positive deflection
in the QRS complex.
Myocardial Infarction
We used the ECGs and the end point registry of hospital
admissions for MI to categorize the patients into 3 groups: (1)
no MI, (2) unrecognized MI, and (3) recognized MI. We defined
participants with unrecognized MI as those with findings of MI
on the ECG in Tromsø 6 without any clinical event in the end
point registry or a registered silent MI in the end point registry
up to the date of examination (diagnosis of MI based on
echocardiography, ECG, or radionuclide angiogram). We
defined participants with recognized MI as those with a
clinical event of definite or probable MI, defined as typical or
atypical symptoms with either ECG findings of acute MI or
elevated cardiac biomarkers.
Selection of Potential Confounding Variables
We selected age, diabetes mellitus, sex, hypertension,
depression, anxiety, physical activity, and smoking as poten-
tial confounding variables. Age, diabetes mellitus, and female
sex have previously been reported to be associated with
increased risk for unrecognized MI6,7,10,21,22 and are also
associated with pain sensitivity.23–25 Diabetes mellitus was
defined as glycated hemoglobin >6.5 or use of antidiabetic
medication. Hypertension is a risk factor for unrecognized
MI,21 and an association between increasing blood pressure
and hypoalgesia has been demonstrated.26–28 We modeled
systolic blood pressure as a continuous variable and also
included current use of blood pressure–lowering medication.
We modeled hypertension (defined as systolic blood pressure
>140 mm Hg, diastolic blood pressure >90 mm Hg or use of
antihypertensive medication) as a dichotomous variable for
interaction analyses. Depression and anxiety has been
reported to be differently associated with unrecognized and
recognized MI,29 and is associated with increased risk for pain
disorders.30,31 Depression/anxiety was measured by Hopkin
symptom checklist 10-item version, and modeled as a
dichotomous variable (cutoff ≤1.85). Physical activity is
considered protective of coronary heart disease32,33 and
was reported to relate to pain sensitivity.34 Physical activity
was self-reported and divided into 3 levels based on the
participants’ answer to the question of whether their average
physical activity in leisure time was limited to “reading,
watching TV, or other sedentary activity,” “walking, cycling, or
other forms of exercise at least 4 hours a week” (eg, walking
or cycling to place of work, Sunday walking),” or “participation
in recreational sports, heavy gardening, etc (note: duration of
activity at least 4 hours a week).” It was modeled as a
categorical variable. Smoking is an established cardiovascular
risk factor that is also linked to pain sensitivity.35 Smoking
was self-reported and defined as “current daily smoker,”
“former daily smoker,” or “never daily smoker” and modeled
as a categorical variable.
Statistical Analyses and Data Management
We calculated descriptive statistics for 3 groups: participants
with recognized MI, participants with unrecognized MI, and
participants without MI. We used Pearson’s chi-square test to
compare categorical variables and t test to compare contin-
uous variables between unrecognized and recognized MI.
We used the Cox proportional hazard model to compare cold
pressor tolerance between unrecognized and recognized MI.
Since we could only study the association between cold pressor
pain and MI and not causality, and because time to withdrawal
of the hand is right-censored data, we used time to withdrawal
as the time to event in the Coxmodel. Data were right-censored
if the participant endured the cold pressor test to the maximum
106 seconds. Participants with no prior MI were excluded from
the main analyses. MI was included as a binary variable (prior
recognized MI, prior unrecognized MI). We used participants
with recognized MI as the reference group. Hazard ratios (HRs)
of aborting the cold pressor test were calculated with 95% CIs.
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Compared with the reference group, HRs <1 indicated higher
tolerance, whereas HRs >1 indicated lower tolerance for pain.
Potential confounding factors (listed in Table 1) were included
in multivariable models. We examined interactions by adding
cross-product terms of MI group and each of the potential
confounding variables to the model. Evaluation of Schoenfeld
residuals and inspection of log-log survival plots did not indicate
that the proportional hazards assumption was violated. We
performed additional analyses including participants without
MI, using this group as a reference group. This was done to
describe the relationship of pain sensitivity in the general
population without MI with that of persons with unrecognized
and recognizedMI. All analyseswere preplanned and performed
in STATA (version 12.0, Stata Corp, College Station, TX).
We also calculated descriptive statistics for participants
included (had undergone cold pressor test and had valid ECG)
and excluded (not undergone cold pressor test or no valid
ECG) from our analyses.
Results
Women had fewer MIs than men (7% versus 19%, P<0.001),
but a larger proportion of MIs were unrecognized in women
than in men (75% versus 58%, P<0.001). Unrecognized MI was
present in 387 (8%) and recognized MI in 227 (4.7%) of the
4849 included participants. Baseline characteristics, by MI,
are shown in Table 1.
Pain Tolerance and Presentation of MI
A total of 1509 participants (31%) aborted the cold pressor test
before the maximum time of 106 seconds. Fewer participants
Table 1. Characteristics of the Study Population by MI Status––The Tromsø Study, 2007–2008
No Prior MI (n=4235) Unrecognized MI (n=387) Recognized MI (n=227) P Value*
Age, y 629 648 688 <0.001
Women 2482 (59) 145 (37) 49 (22) <0.001
Systolic blood pressure, mm Hg 13922 14423 13923 0.01
Current use of blood pressure medication 1032 (24) 125 (32) 127 (56) <0.001
Hypertension† 2380 (56) 255 (66) 168 (74) 0.036
Smoking habits 0.002
Current daily smoker 789 (19) 63 (17) 38 (17)
Former daily smoker 1935 (46) 195 (52) 142 (64)
Never daily smoker 1511 (36) 129 (33) 47 (21)
Diabetes mellitus‡ 279 (7) 35 (9) 28 (12) 0.20
Physical activity 0.65
Sedentary lifestyle (reading, watching TV) 698 (18) 72 (21) 41 (21)
Walking, cycling, or other forms of exercise >4 h/wk 2544 (66) 218 (62) 123 (63)
Participation in recreational sports, heavy gardening, etc >4 h/wk 651 (16) 59 (17) 30 (16)
Psychological distress (HSCL-10 score >1.85) 483 (10) 32 (8) 25 (11) 0.26
Cold pressor tolerance <106 s 1338 (32) 95 (25) 76 (33) 0.02
Medication use
Antiplatelet drugs 399 (9) 73 (19) 188 (83) <0.01
Anticoagulants 81 (2) 13 (3) 32 (14) <0.01
Statins 498 (12) 82 (21) 200 (88) <0.01
b-Blockers 418 (10) 65 (17) 172 (76) <0.01
ACEIs 582 (14) 79 (20) 84 (37) <0.01
Weekly use of painkillers (with or without prescription) 697 (16) 42 (11) 23 (10) 0.78
Values are expressed as meanSD or number (percentage). ACEIs indicates angiotensin-converting enzyme inhibitors; HSCL-10, Hopkin symptom checklist 10-item version; MI,
myocardial infarction.
*t or chi-square tests comparing unrecognized and recognized MI.
†Defined as systolic blood pressure >140 mm Hg, diastolic blood pressure >90 mm Hg, or use of antihypertensive medication.
‡Defined as glycated hemoglobin >6.5 or use of antidiabetic medication.
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with unrecognized MI aborted the cold pressor test compared
with those with recognized MI (25% versus 33%, P<0.02).
Figure 2 shows Kaplan–Meier curves for time to aborting the
cold pressor test, by MI and sex. HRs for aborting the cold
pressor test, by MI and sex, are shown in Table 2. Participants
with unrecognized MI endured the cold pressor test signifi-
cantly longer than participants with recognized MI (HR for
aborting the cold pressor test, 0.64; CI, 0.47–0.88). After
adjustment for additional potential confounding factors (mean
systolic blood pressure, use of blood pressure–lowering drugs,
diabetes mellitus, daily smoking, psychological distress, and
physical activity), the association was attenuated and non-
significant, but the direction of the effect was unaltered.
Sex Differences
More women aborted the cold pressor test compared with men
(38% versus 23%, P<0.0001); however, the association between
pain tolerance and infarct recognition was not significantly
different in men and women (P for interaction=0.14). We also
investigated whether the association between infarct recogni-
tion and pain tolerance varied with the potential confounders
differently in men and women, and none of these 3-way
interactions were significant (results not shown).
Interaction Analyses
We did not find any statistically significant interaction
between groups of MI and systolic blood pressure (P=0.77),
hypertension (yes/no) (P=0.32), use of blood pressure–
lowering drugs (P=0.10), diabetes mellitus (P=0.66), daily
smoking (P=0.32), psychological distress (P=0.48), or phys-
ical activity (P=0.58) with regards to pain tolerance.
Additional Analyses
Table S1 shows additional analyses by adding participants
without MI and using this group as the reference group.
Participants with unrecognized MI did not endure the cold
pressor test statistically significantly longer than participants
without MI (HR for aborting the cold pressor test, 0.84; 95%
CI, 0.68–1.03). Participants with recognized MI endured the
cold pressor test significantly shorter than participants
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Figure 2. Kaplan–Meier plot for aborting the cold pressor test,
by myocardial infarction (MI) status in women (A) and men (B) The
Tromsø Study, 2007–2008.
Table 2. HRs for Cold Pressor Tolerance (Aborted Cold
Pressor Test), by MI Status and Sex––The Tromsø Study,
2007–2008
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0.75 0.49–1.12 0.81 0.50–1.31
HRs indicates hazard ratios; MI, myocardial infarction.
*The analyses of both women and men were adjusted for sex.
†Adjusted for sex, age, mean systolic blood pressure, use of blood pressure–lowering
drugs, diabetes mellitus, daily smoking, psychological distress, and physical activity.
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Table S2 shows descriptive statistics for participants
excluded and included in our analyses. The excluded partic-
ipants were older (629 versus 6610 years), more often
women (55% versus 60%), hypertensive (58% versus 64%), and
above the cutoff of 1.85 for the HSCL score for psychological
distress (11% versus 14%).
Discussion
The main finding of the present study is that participants with
unrecognized MI had higher pain tolerance compared with
participants with recognized MI. Our results suggest that
differences in pain sensitivity affect the perception of MI.
To our knowledge, no previous study has examined pain
tolerance in persons with recognized and unrecognized MI.
However, 2 studies have examined pain sensitivity in patients
hospitalized in the acute phase of MI. One study of 92 MI
patients found that patients with painful acute MI had
increased sensitivity to heat pain compared with patients
with painless acute MI.36 Another study of 67 persons with
ST-elevation MI found an association between conditioned
pain modulation (a test of pain inhibition) and increased
patient delay in seeking treatment, suggesting that more
efficient pain inhibition reduced pain presentation in acute
MI.37 Both studies examined hospitalized patients in the acute
phase of MI and are not directly comparable to our study.
However, they imply that increased pain tolerance is associ-
ated with less symptomatic MI.
Our findings propose that pain tolerance is associated with
recognition of MI. It is plausible that ischemic myocardial pain
is modulated through similar central processes as other pain
modalities, such as cold pressor pain. This can partly explain
our results. Experimental studies have shown that asymp-
tomatic ischemia is associated with attenuated response to
pain.38–40 Differences in central modulation of pain have been
proposed as part of the explanation for absence of pain in
silent ischemia. Activation of the thalamus is seen in both
angina and silent ischemia, but activation of the frontal cortex
seems to be necessary for the conscious sensation of
myocardial pain.13,41 Comparison of peripheral nerve conduc-
tion has shown similar conduction in patients with angina and
silent myocardial ischemia, signifying that peripheral nerve
transmission is not altered.40
It is possible that the size of MI and differences in
pathophysiology also influence symptom severity. A recent
study reported that coronary microvascular dysfunction was
related to silent positive exercise testing in persons with normal
coronary arteries,42 suggesting a different pathophysiology
between silent and symptomatic myocardial ischemia. Studies
also indicate that unrecognized MIs are smaller43,44 and
manifest less regional wall-motion abnormalities45,46 than
recognized MIs. However, other studies show no association
between pain ratings and the ischemic area at risk or MI
size,37,47,48 suggesting that MI size cannot be reliably assessed
by the patient’s symptoms. In the present study, we did not have
the opportunity to study these potential influencers on infarct
recognition.
Additional analyses shown in Table S1 demonstrate that
participants with unrecognized MI do not have a statistically
significantly lower pain tolerance than those with no MI. It is,
however, possible that personswith noMI have a pain tolerance
intermediate to unrecognized and recognized MI, as Figure 2
indicates. However, we cannot exclude the possibility that it is
patients with recognized MI who have an increased pain
sensitivity compared with those without MI and with unrecog-
nizedMI. However, the main purpose of this article was to study
differences between recognized and unrecognized MI.
Sex Differences
Women are more likely to present without chest pain or to
have atypical symptoms in the setting of an acute MI,2,49 and
the proportion of unrecognized MI is larger in women
compared with men.8,15,50 Most studies of experimental pain
show significant sex differences, although sometimes rela-
tively minor and affected by numerous confounding vari-
ables.51,52 When differences are observed, they consistently
show that women have higher sensitivity and lower tolerance
to pain than men.53,54 It therefore seems contradictory that
women have more unrecognized MIs.
As in previous studies, we found a higher proportion of
unrecognized MIs in women and that women were less
tolerant to pain than men. We found that the association
between unrecognized MI and lower pain tolerance was
stronger in women than in men, and statistically significant in
women only, but the sex difference was not statistically
significant (P for interaction=0.14). It is possible that the
larger proportion of unrecognized MIs in women is explained
by the fact that they are more likely to have coronary disease
misdiagnosed or dismissed because of deficient knowledge
and more difficult diagnostics, and not because they do not
experience symptoms of the MI. In addition, it might also be
that women recognized as having an MI are those most
sensitive to pain, presenting with the most severe symptoms,
and therefore are more likely to receive a diagnosis. This can
potentially explain the stronger association in women, as we
have investigated pain sensitivity in those with unrecognized
MI relative to those with recognized MI.
Pain Sensitivity and Clinical Implications
This study contributes to increased awareness of unrecognized
MI. More specifically, it contributes to the knowledge that pain
tolerance affects the presentation of MI. Absence of chest pain
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should not lower alertness of doctors towards ischemic heart
disease. Questions on pain sensitivity or factors that affect this
might be important in the assessment of patients at risk for
cardiovascular disease. ECG is a low-cost and widely available
investigative method and should be considered in persons with
high cardiovascular risk despite no history of chest pain. Pain is
a common symptom when seeking medical assistance and is a
crucial factor in how health workers recognize and assess the
severity of a disease. An increasing body of evidence suggests
that pain sensitivity modulates the clinical expression of
disease.55,56 The present study adds to this by showing that
pain sensitivity may be of importance in the recognition of MI
and contributes with an important aspect to the further
research of underlying reasons for unrecognized MI. We
encourage researchers of future studies in this field to consider
including variables associated with pain sensitivity.
Strengths and Limitations
Strengths of the present study include the population-based
design, large sample size, rigorous validation of previous
recognized MI, and that the technicians were blinded to MI
status. There are also some limitations. First, as Q-wave
criteria were used to identify those with unrecognized MI,
there is probably a larger proportion of non–Q-wave MIs
among participants with recognized compared with unrecog-
nized MI. It is unknown whether this may have affected the
results. Second, we do not know whether participants with
unrecognized MI experienced symptoms or whether the MIs
were truly silent. Third, more women with increased risk
factor levels were excluded from the analyses because they
had not undergone the cold pressor test or had no valid ECG.
Our main results indicate that the ability of this study to
detect differences in pain tolerance between persons with
unrecognized and recognized MI, and possibly sex differences,
were attenuated because of these differences. Fourth, the
cross-sectional design precludes causal inference. Last, the
external validity refers to Caucasian middle-aged and elderly
adults and may not be generalizable to other groups.
Conclusions
Our findings suggest that persons who experience unrecog-
nized MI have reduced pain sensitivity compared with persons
who experience recognized MI, adjusting for age and sex. This
may partially explain the lack of symptoms associated with
unrecognized MI.
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Table S1. Hazard ratios (HRs) for cold pressor tolerance (aborted cold pressor test) with no prior myocardial 
infarction (MI) as reference, by MI status and sex. The Tromsø Study 2007-08. 
 
 Adjusted for age and sex*  Multivariable adjusted** 
 HR 95% CI  HR 95% CI 
Women and Men      
   No prior MI (n=4,235) 1.00 -  1.00 - 
   Prior unrecognized MI(n=387) 0.84 0.68-1.03  0.79 0.63-0.99 
   Prior recognized MI (n=227) 1.30 1.02-1.65   1.08 0.82-1.43 
      
Women only      
   No prior MI (n=2,482) 1.00 -  1.00 - 
   Prior unrecognized MI(n= 145) 0.84 0.62-1.12  0.78 0.56-1.09 
   Prior recognized MI (n=49) 1.75 1.21-2.52  1.30 0.81-2.06 
      
Men only      
  No prior MI (n=1,753) 1.00 -  1.00 - 
  Prior unrecognized MI (n=242) 0.83 0.61-1.11  0.79 0.57-1.10 
  Prior recognized MI (n=178) 1.07 0.78-1.47  1.02 0.72-1.44 
    
*The analyses of both women and men were adjusted for sex 
**Adjusted for sex, age, mean systolic blood pressure, use of blood pressure lowering drugs, diabetes, daily 
smoking, psychological distress and physical activity. 











Age in years 62 ±9 66 ±10 
Women 2,173(45%) 1,489 (60%) 
Blood pressure 





 Systolic blood pressure in mmHg 140 ±23  143±24 
 Hypertension  2,803 (58 %) 1,579 (64%) 
Smoking habits   
 Current daily smoker 899 (19%) 439 (18%) 
 Former daily smoker 





Diabetes* 342(7%) 192 (8%) 
Physical activity   
 Sedentary lifestyle (Reading, watching TV) 811 (18%) 468(22%) 
 Walking, cycling, or other forms of exercise > 4   
hours a week 
2885 (65%) 1333 (63%) 
Participation in recreational sports, heavy 
gardening, etc. >4 h a week 
720 (16%) 339 (16%) 









Psychological distress (HSCL-10 score >1.85) 540 (11%) 343 (14%) 
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